Pearls in the management of submacular hematoma

Seminars in Ophthalmology

Volumn 13, Issue 1, 1998, Pages 40-51

  Ikuno, Yasushi ^a   Lewis, John Michael ^b   Kamei, Motohiro ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Retinal Diagnostic Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; ASPIRATION; CATARACT; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; EPIRETINAL MEMBRANE; FIBRINOLYSIS; HEMATOMA; HUMAN; PATHOPHYSIOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HEMORRHAGE; SUBRETINAL NEOVASCULARIZATION; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VISUAL ACUITY; VITRECTOMY;

EID: 0031944666     PISSN: 08820538     EISSN: None     Source Type: Journal    
DOI: 10.3109/08820539809066081     Document Type: Article

References (29)

1. Bloome MA, Ruiz RS. Massive spontaneous subretinal hemorrhage. Am J Ophthalmol 1978;86:630-637.
2. Bennett SR, Folk JC, Blodi CF, et al. Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol. 1990;109:33-37.
3. Avery RL, Fekrat S, Hawkins BS, et al. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina. 1996;16:183-189.
4. Bercow JW, Font RL. Disciform macular degeneration with subpigment epithelial hematoma. Arch Ophthalmol. 1969; 82:51-56.
5. Silva SB, Brockhurst RJ. Hemorrhagic detachment of the peripheral retinal pigment epithelium. Arch Ophthalmol. 1976; 94:1295-1300.
6. Kreiger AE, Haidt SJ. Vitreous hemorrhage in senile macular degeneration. Retina. 1983;3:318-321.
7. Macular photocoagulation study group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: Results of randomized clinical trial. Arch Ophthalmol. 1991;109:1220-1231.
8. Luxenburg MN. Early surgical drainage of macular subretinal hemorrhage. Arch Ophthalmol. 1987;105:1722-1723.
9. de Juan E Jr, Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol. 1988;105:25-29.
10. Wade EC, Flynn HW Jr, Olsen KR, et al. Subretinal hemorrhage management by pars plana vitrectomy and internal drainage. Arch Ophthamol. 1990;108:973-978.
11. Vander JF, Federman JI, Greven C, et al. Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration. Ophthalmology. 1991;98: 23-27.
12. Peyman GA, Paris CL, Nelson NC, et al. Tissue plasminogen activating factor assisted removal of subretinal hemorrhage. Ophthalmic Surg. 1991;22:575-582.
13. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol. 1994;118:559-568.
14. Lim JI, Drews-Botsch C, Sternberg P Jr, et al. Submacular hemorrhage removal. Ophthalmology. 1995;102:1393-1399.
15. Ibanez HE, Williams DF, Thomas MA, et al. Surgical management of submacular hemorrhage: Results of 47 consecutive cases. Arch Ophthalmol. 1995:113:62-69.
16. Kamei M, Tano Y, Maeno T, et al. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol. 1996;121:267-275.
17. Decker WL, Sanborn GE, Ridley M, et al. Retinal pigment epithelial tears. Ophthalmology. 1983;90:507-512.
18. Gass JDM. Retinal pigment epithelial rip during krypton red laser photocoagulation. Am J Ophthalmol. 1984;89:700-706.
19. Berrocal MH, Lewis ML, Flynn HW Jr. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol. 1996;122:486-493.
20. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol. 1982;94:762-773.
21. Toth CA, Morse LS, Hjelmeland LM, et al. Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol. 1991;109:723-729.
22. Lewis H, Resnick SC, Flanney JG, et al. Tissue plasminogen activator treatment of experimental hemorrhage. Am J Ophthalmol. 1991;111:197-204.
23. Toth CA, Benner JD, Hjelmeland LM, et al. Untramicrosurgical removal of subretinal hemorrhage in cats. Am J Ophthalmol. 1992;113:175-182.
24. Johnson MW, Olsen KR, Hernandez E. Tissue plasminogen activator thrombolysis during surgical evacuation of experimental subretinal hemorrhage. Ophthalmology. 1992;99:515-521.
25. Thompson JT, Glaser BM, Sjaarda RN, et al. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol. 1995;119:48-54.
26. Cherfan GM, Michels RG, de Bustros S, et al. Nuclear sclerotic cataract after vitrectomy for idiopathic epiretinal membranes causing macular pucker. Am J Ophthalmol. 1991;111: 434-438.
27. Berner JD, Hay A, Landers MB III, et al. Fibrinolyticassisted removal of experimental subretinal hemorrhage within seven days reduces outer retinal degeneration. Ophthalmology. 1994;101:672-681.
28. Kimura AE, Reddy CV, Folk JC, et al. Removal of subretinal hemorrhage facilitated by preoperative intravitreal tissue plasminogen activator. Retina. 1994;14:83-84.
29. Boone DE, Boldt HC, Ross RD, et al. The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model. Retina. 1996;16:518-524.